Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP596610.RASRZYNPUOqRGkorEiXohPuCRatM9VQJjco-il9dnDnfY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP596610.RASRZYNPUOqRGkorEiXohPuCRatM9VQJjco-il9dnDnfY130_assertion type Assertion NP596610.RASRZYNPUOqRGkorEiXohPuCRatM9VQJjco-il9dnDnfY130_head.
- NP596610.RASRZYNPUOqRGkorEiXohPuCRatM9VQJjco-il9dnDnfY130_assertion description "[Evaluation of the expression of three T-cell malignancy associated genes showed that Rhombotin-2 (RBTN-2 also known as Lmo-2), TAL-1 (also known as SCL), and HOX-11 were expressed in 100%, 40%, and 0% of the murine tumors, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP596610.RASRZYNPUOqRGkorEiXohPuCRatM9VQJjco-il9dnDnfY130_provenance.
- NP596610.RASRZYNPUOqRGkorEiXohPuCRatM9VQJjco-il9dnDnfY130_assertion evidence source_evidence_literature NP596610.RASRZYNPUOqRGkorEiXohPuCRatM9VQJjco-il9dnDnfY130_provenance.
- NP596610.RASRZYNPUOqRGkorEiXohPuCRatM9VQJjco-il9dnDnfY130_assertion SIO_000772 9116269 NP596610.RASRZYNPUOqRGkorEiXohPuCRatM9VQJjco-il9dnDnfY130_provenance.
- NP596610.RASRZYNPUOqRGkorEiXohPuCRatM9VQJjco-il9dnDnfY130_assertion wasDerivedFrom befree-20140225 NP596610.RASRZYNPUOqRGkorEiXohPuCRatM9VQJjco-il9dnDnfY130_provenance.
- NP596610.RASRZYNPUOqRGkorEiXohPuCRatM9VQJjco-il9dnDnfY130_assertion wasGeneratedBy ECO_0000203 NP596610.RASRZYNPUOqRGkorEiXohPuCRatM9VQJjco-il9dnDnfY130_provenance.